Novonesis (Novozymes) NOVONESIS B ORD SHS
Novonesis (Novozymes) NOVONESIS B.../ DK0060336014 /
0Q4U
2024-05-24 4:50:45 PM
|
Chg.
-
|
Volume |
Bid4:55:04 PM |
Ask4:55:04 PM |
Market Capitalization |
Dividend Y. |
P/E Ratio |
423.75DKK
|
-
|
11,763 Turnover: 2.57 mill. |
-Bid Size: - |
-Ask Size: - |
127.4 bill.DKK |
0.91% |
42.07 |
Business description
Novozymes is the world leader in biological solutions. As the world’s largest provider of enzyme and microbial technologies, the company´s bioinnovation enables higher agricultural yields, low-temperature washing, energy-efficient production, renewable fuel and many other benefits.
Management board & Supervisory board
CEO |
Ester Baiget |
Management board |
Rainer Lehmann, Amy Byrick, Anders Lund, Claus Crone Fuglsang, Graziela Chaluppe dos Santos Malucelli, Morten Enggaard Rasmussen, Tina Sejersgård Fanø |
Supervisory board |
Cees de Jong, Andreas Hentze Knudsen, Anne Breum, Cees de Jong, Heine Dalsgaard, Jens Øbro, Kasim Kutay, Kim Stratton, Mathias Uhlén, Preben Nielsen, Sharon James |
Company data
Name: |
Novozymes A.S |
Address: |
Krogshoejvej 36,DK-2880 Bagsvaerd |
Phone: |
+45-44-460000 |
Fax: |
- |
E-mail: |
-
|
Internet: |
www.novozymes.com/ |
Industry: |
Biotechnology |
Sector: |
Biotechnology |
Sub sector: |
Biotechnology |
End of financial year: |
12-31 |
Free Float: |
74.50% |
IPO date: |
2000-11-20 |